EP Wealth Advisors LLC Acquires Shares of 21,399 Pediatrix Medical Group, Inc. $MD

Key Points

• EP Wealth Advisors LLC has acquired a new position in Pediatrix Medical Group, Inc. by purchasing 21,399 shares, amounting to approximately $310,000.
• Pediatrix Medical Group has reported a quarterly earnings per share (EPS) of $0.53, surpassing analyst expectations of $0.42, although revenue has decreased by 7.1% year-over-year.
• Various institutional investors have increased their stakes in Pediatrix Medical Group, with 97.71% of the stock now held by institutional investors.

EP Wealth Advisors LLC acquired a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 21,399 shares of the company's stock, valued at approximately $310,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MD. GAMMA Investing LLC increased its holdings in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after buying an additional 1,765 shares during the last quarter. AlphaQuest LLC increased its holdings in Pediatrix Medical Group by 16.0% during the first quarter. AlphaQuest LLC now owns 5,877 shares of the company's stock valued at $85,000 after buying an additional 811 shares during the last quarter. Squarepoint Ops LLC purchased a new stake in Pediatrix Medical Group during the fourth quarter valued at approximately $132,000. Sherbrooke Park Advisers LLC purchased a new stake in Pediatrix Medical Group during the fourth quarter valued at approximately $136,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Pediatrix Medical Group during the first quarter valued at approximately $159,000. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD traded down $0.34 during midday trading on Friday, reaching $16.67. 524,924 shares of the company were exchanged, compared to its average volume of 774,244. Pediatrix Medical Group, Inc. has a one year low of $10.39 and a one year high of $17.67. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.70. The business's fifty day moving average is $14.75 and its two-hundred day moving average is $14.17. The stock has a market cap of $1.45 billion, a PE ratio of 12.92 and a beta of 1.30.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating the consensus estimate of $0.42 by $0.11. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The business had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. During the same quarter last year, the business earned $0.34 earnings per share. Pediatrix Medical Group's quarterly revenue was down 7.1% compared to the same quarter last year. As a group, analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on MD. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.00 to $16.50 and gave the stock a "neutral" rating in a research report on Thursday, August 14th. Zacks Research upgraded shares of Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Wall Street Zen lowered shares of Pediatrix Medical Group from a "strong-buy" rating to a "buy" rating in a research report on Saturday. Finally, Leerink Partners upped their target price on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a "market perform" rating in a research report on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and five have assigned a Hold rating to the company's stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $16.79.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.